4 May 2021 - The Patented Medicine Prices Review Board, through the National Prescription Drug Utilisation Information System research initiative, today published the second in a three part report series on Alignment Among Public Formularies in Canada.
This latest report looks at gaps and overlaps in the coverage and funding of oncology drugs across Canada.